The investigators assembled in the DF/HCC Prostate Cancer SPORE have a substantial record in mentorship and development of junior faculty working in the prostate cancer field (detailed below). The goal of the Career Development Program of our SPORE is to build upon this record and continue a formal process for the identification, selection, funding, and mentoring of individuals pursuing careers in the study of the basic, translational, and clinical aspects of prostate cancer. 1. Solicitation of CDP Award Applications 2. Evaluation of Applicants and Selection of Awardees 3. CDP Evaluation and Review 4. Mentorship for Career Development Program Awardees and Career Progress

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
2P50CA090381-11A1
Application #
8554566
Study Section
Special Emphasis Panel (ZCA1-RPRB-M (M1))
Project Start
2001-04-01
Project End
2018-06-30
Budget Start
2013-09-23
Budget End
2014-06-30
Support Year
11
Fiscal Year
2013
Total Cost
$168,521
Indirect Cost
$86,702
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Dickerman, Barbra A; Ahearn, Thomas U; Giovannucci, Edward et al. (2017) Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer. Int J Cancer 141:933-944
Cacciatore, Stefano; Zadra, Giorgia; Bango, Clyde et al. (2017) Metabolic Profiling in Formalin-Fixed and Paraffin-Embedded Prostate Cancer Tissues. Mol Cancer Res 15:439-447
Sinnott, Jennifer A; Peisch, Sam F; Tyekucheva, Svitlana et al. (2017) Prognostic Utility of a New mRNA Expression Signature of Gleason Score. Clin Cancer Res 23:81-87
Zareba, Piotr; Flavin, Richard; Isikbay, Masis et al. (2017) Perineural Invasion and Risk of Lethal Prostate Cancer. Cancer Epidemiol Biomarkers Prev 26:719-726
Han, W; Gao, S; Barrett, D et al. (2017) Reactivation of androgen receptor-regulated lipid biosynthesis drives the progression of castration-resistant prostate cancer. Oncogene :
McKay, Rana R; Werner, Lillian; Mostaghel, Elahe A et al. (2017) A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res 23:935-945
Qu, Fangfang; Xie, Wanling; Nakabayashi, Mari et al. (2017) Association of AR-V7 and Prostate-Specific Antigen RNA Levels in Blood with Efficacy of Abiraterone Acetate and Enzalutamide Treatment in Men with Prostate Cancer. Clin Cancer Res 23:726-734
Graff, Rebecca E; Ahearn, Thomas U; Pettersson, Andreas et al. (2017) Height, obesity, and the risk of TMPRSS2:ERG-defined prostate cancer. Cancer Epidemiol Biomarkers Prev :
Liu, Xiaming; Gao, Yanfei; Ye, HuiHui et al. (2017) Positive feedback loop mediated by protein phosphatase 1? mobilization of P-TEFb and basal CDK1 drives androgen receptor in prostate cancer. Nucleic Acids Res 45:3738-3751
Tyekucheva, Svitlana; Bowden, Michaela; Bango, Clyde et al. (2017) Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer. Nat Commun 8:420

Showing the most recent 10 out of 240 publications